Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

ConclusionsThe data may indicate that in people with Type 2 diabetes, which is associated with higher alanine aminotransferase levels because of prevalent non‐alcoholic fatty liver disease, a low alanine aminotransferase level is a marker of hepatic or systemic frailty rather than health.This article is protected by copyright. All rights reserved.

Source: Diabetic Medicine - October 3, 2015 Category: Endocrinology Authors: K. H. Williams, D. R. Sullivan, A. S. Veillard, R. O'Brien, J. George, A. J. Jenkins, S. Young, C. Ehnholm, A. Duffield, S. M. Twigg, A. C. Keech Tags: Research Article Source Type: research